iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by AFT Forsyth & Company Inc.

AFT Forsyth & Company Inc. lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,209 shares of the financial services provider’s stock after selling 153 shares during the period. AFT Forsyth & Company Inc.’s holdings in iShares Biotechnology ETF were worth $556,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of IBB. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $4,161,000. Certuity LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth $454,000. Comprehensive Financial Planning Inc. PA bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at $47,000. Angeles Wealth Management LLC boosted its holdings in shares of iShares Biotechnology ETF by 2,083.3% during the fourth quarter. Angeles Wealth Management LLC now owns 524 shares of the financial services provider’s stock valued at $69,000 after acquiring an additional 500 shares during the period. Finally, Martin Capital Advisors LLP boosted its holdings in shares of iShares Biotechnology ETF by 9.6% during the fourth quarter. Martin Capital Advisors LLP now owns 14,439 shares of the financial services provider’s stock valued at $1,909,000 after acquiring an additional 1,270 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.9 %

IBB stock opened at $135.47 on Thursday. The firm’s 50-day simple moving average is $135.88 and its 200 day simple moving average is $141.13. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.